10/20/2026
This week, I will be at the Hilton Bayfront for the annual conference of The Menopause Society.
This is my first time attending.
How could I not attend considering it's in my backyard.
We finally have traction in women's health.
In the past two weeks the American College of Physicians finally named estrogen the first-line treatment for hot flashes and night sweats.
The ACOG published its first full menopause guideline since 2014, with a strong recommendation for hormone therapy for hot flashes and the sleep problems they cause.
For those of us who have spent years explaining to women that the 2002 headlines did us a huge disservice, that is a big deal.
At the same time, we are still working around the estradiol patch shortage, and women are calling pharmacy after pharmacy to fill a prescription their doctor finally agreed to write. It’s hard to believe it is still going on.
Here are some highlights on what the conference is about.
The question I most want answered is about breast cancer.
There is a full symposium on the cost of avoiding estrogen, including in breast cancer survivors, and I want to hear whether the thinking for women with estrogen receptor positive cancer is getting more nuanced or are we just saying a blanket NO! for women with hormone positive breast cancer.
Stay tuned.